Suppr超能文献

[透明细胞乳头状肾细胞癌的临床病理及预后特征]

[Clinicopathological and prognostic characteristics of clear cell papillary renal cell carcinoma].

作者信息

Xu Y W, Zhou J C, Xie H B, Yang W P, Li L, Zhang K N, Ma K F, Gong Y Q, Zhang Z, Cai L, Gong K

机构信息

Department of Urology, Peking University First Hospital, the Institute of Urology, Peking University, National Urological Cancer Center, Beijing 100034, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2021 Dec 14;101(46):3784-3788. doi: 10.3760/cma.j.cn112137-20210701-01482.

Abstract

To analyze the epidemiological, clinicopathological and prognostic characteristics of clear cell papillary renal cell carcinoma (CCPRCC) based on Chinese patient population. Patients with renal cell carcinoma diagnosed at Peking University First Hospital from June 2016 to June 2020 were included in this study based on the inclusion and exclusion criteria. All cases were grouped according to CCPRCC, clear cell renal cell carcinoma (ccRCC), and papillary renal cell carcinoma (pRCC), and the general clinical, postoperative pathological and follow-up data of the patients were retrospectively analyzed. A total of 18 CCPRCC patients were enrolled in this study, accounting for 0.44% (18/4 110) of the postoperative pathologically confirmed renal cell carcinoma cases in our hospital during this time period. The age range of the included patients was 28-86 years old, with a median age of 49.5 years old. There were 11/18 males and 7/18 females. All CCPRCC patients had no family history of renal malignant tumors. Among them, only one patient with CCPRCC had related clinical symptoms, that was intermittent waist and abdomen pain, while the other 17 cases were found by physical examination without any related symptoms. Compared with ccRCC and pRCC, there was no significant difference in their end stage renal disease history(χ=0.291, χ=1.161,all 0.05). The maximum diameter of CCPRCC tumor was smaller than pRCC (χ=-2.280, =0.027) but not significantly different from ccRCC (χ=-0.579, =0.565). The majority of patients with CCPRCC were in pT1, their pathological stage was earlier than the other two types, and their overall survival was better than ccRCC and pRCC (0.05). CCPRCC is a type of renal cell carcinoma with unique epidemiology, clinicopathology and prognostic characteristics. Patients with this subtype have an earlier clinical stage and a better prognosis than ccRCC and pRCC.

摘要

基于中国患者群体,分析透明细胞乳头状肾细胞癌(CCPRCC)的流行病学、临床病理及预后特征。根据纳入和排除标准,将2016年6月至2020年6月在北京大学第一医院确诊为肾细胞癌的患者纳入本研究。所有病例按照CCPRCC、透明细胞肾细胞癌(ccRCC)和乳头状肾细胞癌(pRCC)进行分组,并对患者的一般临床、术后病理及随访数据进行回顾性分析。本研究共纳入18例CCPRCC患者,占同期我院术后病理确诊肾细胞癌病例的0.44%(18/4110)。纳入患者的年龄范围为28 - 86岁,中位年龄为49.5岁。男性11/18例,女性7/18例。所有CCPRCC患者均无肾恶性肿瘤家族史。其中,仅有1例CCPRCC患者有相关临床症状,即间歇性腰腹痛,其余17例通过体检发现,无任何相关症状。与ccRCC和pRCC相比,其终末期肾病病史无显著差异(χ=0.291,χ=1.161,均P>0.05)。CCPRCC肿瘤的最大直径小于pRCC(χ=-2.280,P=0.027),但与ccRCC无显著差异(χ=-0.579,P=0.565)。CCPRCC患者多数为pT1期,其病理分期早于其他两种类型,总生存期优于ccRCC和pRCC(P<0.05)。CCPRCC是一种具有独特流行病学、临床病理及预后特征的肾细胞癌类型。该亚型患者的临床分期早于ccRCC和pRCC,预后较好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验